Indian specialty-materials startup Scimplify raised $25 million in an all-equity strategic round led by Hitachi Ventures, with customers Henkel and Teknor Apex joining as investors. Existing backers also participated. The funding brings total equity raised to about $80 million, according to the company.
Scimplify’s pitch is not simply that artificial intelligence discovers chemicals. It combines software-assisted formulation and process development with a network of more than 500 manufacturing facilities. Management says that model can cut the time from customer specification to finished material to as little as two months, versus 12 to 18 months in some conventional projects.
The company reports an annualized revenue run rate near $200 million, three times the level a year earlier, and a target of $400 million over the next year. It serves more than 1,000 customers in over 40 countries. Those are management figures, not audited financial statements, and annualized run rate is not the same as recognized annual revenue. A recent large month can make the run rate look stronger than the full-year result.
Control is the hard part
About 90% of current manufacturing takes place in India, while customers outside India contribute more than half of revenue, according to management. Scimplify plans to spend about $7.5 million on U.S. research, processing and manufacturing capacity and another $2 million on its Scinode software platform. The shift could improve access to customers seeking non-Chinese supply, but it adds regulatory, quality-control and working-capital demands.
The partner-network model can reduce the need to own every plant. It can also make consistency harder across regulated products used in semiconductors, batteries, defense and energy. Customer qualification cycles, batch reproducibility and intellectual-property protection will determine whether the model scales beyond initial projects.
Strategic investors provide useful validation because Henkel and Teknor Apex understand materials markets. Their participation does not guarantee commercial orders or economics. The next evidence should include audited revenue, gross margin, repeat orders, customer concentration and qualification timelines.
Scimplify is addressing a real supply-chain problem, and its reported growth is unusually fast. The investment case remains private and early, with the biggest question shifting from demand generation to reliable execution across a distributed manufacturing base.